Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF- κB pathway

CONCLUSION: In summary, our study confirmed that HQD mitigates lipid metabolism disorders and insulin resistance in NAFLD by triggering the Sirt1/NF-κB pathway.PMID:37664157 | PMC:PMC10473922 | DOI:10.3748/wjg.v29.i31.4744
Source: World Journal of Gastroenterology : WJG - Category: Gastroenterology Authors: Source Type: research